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In previous studies we observed that normal human
epidermis forms 12-oxo-eicosatetraenoic acid (12-
oxo-ETE) and hepoxilin B3 (HxB3) as major eicosa-
noids, both being elevated in psoriasis. We also
observed that normal epidermis, in a reaction prob-
ably catalyzed by 12-lipoxygenase, only synthesize
one of the two possible 10-hydroxy epimers of
HxB3. We have now extended these previous studies
investigating further transformation of HxB3 into
trioxilin B3 (TrXB3) and esteri®cation of both into
phospholipids. Phospholipids were extracted from
normal epidermis and from psoriatic scales. A com-
bination of high performance liquid chromatography
and gas chromatography±mass spectrometry analysis
demonstrated the occurrence of HxB3 and TrXB3 in
the phospholipids of psoriatic lesions. Alkaline- and
phospholipase-A2-mediated hydrolysis of the phos-
pholipids yielded similar quantities of both HxB3
and TrXB3 indicating their preference for the sn-2
position of glycerophospholipids. The thin layer
chromatography analysis of the phospholipid classes
after incubation of epidermal cells with [14C]-labeled
HxB3, TrXB3, 12-hydroxy-eicosatetraenoic acid (12-
HETE), 12-oxo-ETE, or 15-HETE showed that 12-
HETE was the most esteri®ed (12-HETE >15-HETE
> TrXB3 > 12-oxo-ETE > HxB3). HxB3 and TrXB3
were mainly esteri®ed in phosphatidyl-choline and
phosphatidyl-ethanolamine. HxB3 was also enzyma-
tically converted into TrXB3 in vitro. HxB3 epoxide
hydrolase-like activity was not observed when boiled
tissue was incubated with [14C]-HxB3, this activity
being located in the cytosol fraction (100,000 3 g
supernatant) of fresh tissue. These ®ndings suggest
that in vivo some part of HxB3 is transformed into
TrXB3 and both compounds are partially incorpor-
ated into the phospholipids. Key words: human epider-
mis/12-lipoxygenase/arachidonic acid. J Invest Dermatol
118:139±146, 2002
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2-Lipoxygenase (12-LO) is the major arachidonic acid
(AA) oxygenation pathway in epidermal cells with total
product formation generally exceeding cyclooxygenase
activity (Holtzman et al, 1989; SolaÂ et al, 1992). Platelet-
type 12-LO has been found to be the predominant
isoenzyme expressed in human and murine skin epidermis
(Takahashi et al, 1993; Hussain et al, 1994; Krieg et al, 1995) and
an ``epidermal''-type 12-LO that functionally resembles the
platelet-type 12-LO is also present in murine epidermis (Van
Dijk et al, 1995; Funk et al, 1996; Kinzig et al, 1997). We previously
reported that, in addition to 12-hydroxyeicosatetraenoic acid (12-
HETE), normal human epidermis incubated with exogenous AA
produces 12-oxo-eicosatetraenoic acid (12-oxo-ETE), hepoxilin
A3 (HxA3), and hepoxilin B3 (HxB3) through the 12-LO pathway
(AntoÂn et al, 1995; AntoÂn and Vila, 2000). Recently, we also
observed increased levels of nonesteri®ed hepoxilins and trioxilins
in the psoriatic scales (AntoÂn et al, 1998). Normal human epidermis
synthesized only one of the two possible 10-hydroxy epimers of
HxB3 whose formation is probably catalyzed by 12-LO (AntoÂn et
al, 1995; AntoÂn and Vila, 2000). Hepoxilins exert action on plasma
permeability on skin (Laneuville et al, 1991; Wang et al, 1996,
1999a; 1999b), and induce a speci®c-receptor-dependent Ca2+
mobilization from endogenous sources (Dho et al, 1990; Laneuville
et al, 1993) and the release of AA and diacylglycerol (Nigam et al,
1993). Interestingly, only the epimer 10(R)-HxB3, which is
probably the epimer synthesized by normal epidermis (AntoÂn et
al, 1995; AntoÂn and Vila, 2000), stereospeci®cally enhances the
vascular permeability evoked by intradermal injection of the
platelet-activating factor (Wang et al, 1996; 1999a; 1999b).
On the other hand, less polar eicosanoids and octadecanoids,
such as monohydroxy and epoxy derivatives of arachidonic and
linoleic acids, have been found to esterify into cell phospholipids.
Oxidized phospholipids have pro-in¯ammatory activities and are
involved in atherogenesis, psoriasis, and other in¯ammatory
diseases. In human epidermis, HxB3 can be further converted
into trioxilin B3 (TrXB3, 10,11,12-trihydroxy-5,8,14-eicosatrie-
noic acid) (AntoÂn et al, 1995). As relevant biologic activity for
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trioxilins has not been reported (Pace-Asciak et al, 1999) these
compounds could represent a pathway for hepoxilin inactivation.
Enzymatic transformation of hepoxilins into trihydroxy compound
was originally reported in rat lung (Pace-Asciak et al, 1983). No
data about the enzymatic metabolism of HxB3 in human epidermis
are at present available, however. This prompted us to extend our
previous investigations (AntoÂn et al, 1995; 1998; AntoÂn and Vila,
2000) on the presence of HxB3 in the phospholipid fraction of
psoriatic lesions, on HxB3 incorporation into the different
phospholipid classes in human epidermal cells, and on the
enzymatic pathways involved in the catabolism of HxB3.
MATERIALS AND METHODS
Materials [1±14C]-AA (55±58 mCi per mmol) was supplied by
Amersham IbeÂrica (Madrid, Spain). Phospholipase A2 from bee venom
was supplied by Sigma-Aldrich QuõÂmica (Madrid, Spain). Hydrated
platinum (IV) oxide was purchased from ICN Biochemicals (Costa Mesa,
CA). Hydrogen gas was purchased from AbelloÂ OxõÂgeno-Linde
(Barcelona, Spain). 1-Stearoyl-2-[1±14C]-arachidonoyl-L-3-phosphatidyl-
choline was obtained from Amersham IbeÂrica. (6)-HxB3 were from
Cascade Biochem (Berkshire, U.K.). All high performance liquid
chromatography (HPLC) solvents were supplied by Scharlau (Barcelona,
Spain) and solvents for mass spectrometry analysis and N,O-bis-
(trimethylsilyl)-tri¯uoroacetamide (BSTFA) were purchased from Merck
(Darmstadt, Germany).
Source of normal human epidermis fragments and epidermal cell
suspensions Epidermis was isolated from normal skin, obtained from
plastic surgery, using the Liu and Karasek technique (Liu and Karasek,
1978) with minor modi®cations (SolaÂ et al, 1992). Brie¯y, narrow strips
of skin were cut and rinsed twice in phosphate-buffered saline, pH 7.4,
free of Ca2+ and Mg2+ (PBS*). The strips were then placed in PBS*
containing 0.5% trypsin (wt/vol) (Difco Laboratories, Paisley, Scotland)
and kept at 37°C for 50±60 min. When dermo-epidermal detachment
occurred, epidermal strips were transferred to a culture medium
[Dulbecco's modi®ed Eagle's medium (DMEM) (Flow Laboratories,
Irvine, Scotland) + 2 mM glutamine + 1 mM sodium pyruvate]
containing 10% vol/vol fetal bovine serum (FBS) (Flow Laboratories).
After peeling the epidermis from the dermis, the epidermal fragments
were washed in DMEM. Epidermal fragments were isolated by ®ltration
through a sterile gauze. The remaining sheets were divided into small
fragments with a surgical blade (approximately 1 mm2) and used for
experiments without further manipulation. To obtain epidermal cell
suspensions, after peeling the epidermis from the dermis, the epidermal
fragments were then gently stirred for 10±15 min in DMEM
supplemented with 2 mM glutamine, 1 mM sodium pyruvate, and 10%
vol/vol FBS. The cellular suspension thus obtained was ®ltered through
a sterile gauze to discard fragments of whole epidermis and then kept at
37°C until incubation. Only cell suspensions with viability greater than
95% were used. Fragments of fresh human epidermis and epidermal cell
suspensions were used immediately.
Source of psoriatic scales Scales from untreated patients with
chronic stable plaque psoriasis involving more than 10% of body surface
were removed by scraping with a surgical blade and stored at ±80°C
under an N2 atmosphere until analysis.
Isolation of phospholipid fraction from psoriatic scales Psoriatic
scales (500±700 mg) were cut and mechanically homogenized with a
Turrax T-8 in 3 ml of degassed distilled water containing 0.025½ (wt/
vol) BHT placed in an ice-water bath under an N2 atmosphere. Next,
100,000 cpm of 1-stearoyl-2-([1±14C]-arachidonyl)-phosphatidylcholine
were added as internal standard. Immediately, total lipids were extracted
as described previously (Bligh and Dyer, 1959). Extracts of CHCl3 were
dried under an N2 stream and redissolved in 200 ml of CHCl3.
Phospholipids were separated from free fatty acids and neutral lipids as
described previously (Kaluzny et al, 1985) using solid phase extraction
chromatography. All solvents were supplemented with 0.025½ (wt/vol)
BHT and the extraction was performed under an N2 atmosphere.
Hydrolysis of ester bonds The phospholipid fraction was divided in
two aliquots and phospholipids were hydrolyzed by following two
different procedures: alkaline saponi®cation and treatment with puri®ed
phospholipase A2 (PLA2). For alkaline saponi®cation phospholipid
extracts were dried under an N2 stream, the residue was redissolved in
850 ml of MeOH/CHCl3 8:1, and 150 ml 40% wt/vol KOH were
added. The mixture was allowed to react for 30 min at 60°C under an
N2 atmosphere (KuÈhn et al, 1994). The reaction was stopped by adding
700 ml of 50 mM phosphate buffer pH = 7.4 and acidifying until pH 2±
3. Free fatty acids were then extracted twice with 2 ml diethyl ether/
hexane 1:1. The reaction yield measuring release of [1±14C]-AA from 1-
stearoyl-2-[1±14C]-arachidonoyl-L-3-phosphatidylcholine was about 94%.
For speci®c hydrolysis of the sn-2 position, phospholipid extracts were
dried under an N2 stream, and the residue was redissolved in 10 ml of
CHCl3 and 70 ml of 30 mM borate buffer (pH = 9.0) supplemented
with 1.6 mM CaCl2. The mixture was then shaken vigorously and
CHCl3 was removed under an N2 stream. 850 U of bee venom PLA2 in
85 ml of 30 mM borate buffer pH 9.0 were added and the mixture was
allowed to react for 45 min at 37°C under an N2 atmosphere with
continuous agitation. Afterwards, another 850 U of PLA2 were added
and allowed to react for another 100 min (Smiley et al, 1991). Reaction
was stopped by acidi®cation until pH 2±3 and lipids were extracted as
described by Bligh and Dyer (1959). After analysis of the free [14C]-AA
released from 1-stearoyl-2-[1±14C]-arachidonoyl-L-3-phosphatidylcholine
the yield of the reaction was about 96%.
Preparation of puri®ed [14C]-labeled HxB3, 12-oxo-ETE, and 12-
HETE Labeled 12-LO-derived eicosanoids were obtained from
incubations of fragments of human epidermis, previously treated with
200 mM aspirin for 15 min, with 100 mM [14C]-AA for 30 min at 37°C,
and processed as described previously (AntoÂn and Vila, 2000).
Supernatants of several incubations were mixed and processed together.
Supernatants of the incubations, which had a ratio MeOH:H2O of 1:1
and a pH of 2±3, were extracted three times with half a volume of
diethyl ether:hexane 1:1. Extracts were evaporated under an N2 stream
until dryness, redissolved in the eluent of reverse phase high performance
liquid chromatography (RP-HPLC), and chromatographied as described
later. Fractions containing hepoxilins (14±20 min) and 12-oxo-ETE plus
12-HETE (25±33 min) were collected and puri®ed by straight-phase
HPLC as reported previously (AntoÂn et al, 1995). The speci®c activity of
the labeled compounds was assumed to be the same as the [14C]-AA
batch used in their preparation as AA is labeled in the C of the carboxyl
group, which is conserved in all these compounds.
Preparation of puri®ed [14C]-labeled TrXB3 Labeled TrXB3 was
obtained from incubations of fragments of human epidermis with 10 mM
[14C]-labeled HxB3 for 30 min at 37°C. After the incubation period one
volume of methanol and 1 M HCl to yield a pH of 2±3 were added.
Supernatants of several incubations were mixed and processed together.
These supernatants were then extracted three times with half a volume
of diethyl ether:hexane 1:1. Extracts were evaporated under an N2
stream until dryness, redissolved in the eluent of RP-HPLC, and
chromatographied as described above. The fraction containing TrXB3
(4±11 min) was collected and puri®ed by straight-phase HPLC as
reported previously (AntoÂn et al, 1995). The speci®c activity of the
labeled TrXB3 was assumed to be the same as that of [
14C]-HxB3.
Preparation of puri®ed [14C]-labeled 15-HETE [14C]-15-
hydroperoxyeicosatetraenoic acid (15-HPETE) was obtained by
incubating [14C]-AA with soybean LO and was puri®ed by straight-
phase HPLC, after reduction with NaBH4, as previously described
(Camacho et al, 1995). The speci®c activity of the labeled 15-HETE was
assumed to be the same as that of the [14C]-AA batch used in its
preparation.
Cell fractionation and incubation of cell fractions Epidermis
fragments (1±2 g) were homogenized and microsomal (100,000 3 g
pellet) and cytosolic (100,000 3 g supernatant) fractions were obtained as
described previously (AntoÂn and Vila, 2000) and incubated with 10 mM
[14C]-HxB3 or unlabeled HxB3 (as required) at 37°C for 30 min.
Eicosanoids were analyzed by RP-HPLC, and by gas chromatography±
mass spectrometry (GC-MS) when necessary, as described below.
Esteri®cation of eicosanoids into phospholipids Ten million
epidermal cells in suspension were incubated in 0.5 ml of RPMI-1640
containing 10 mM of [14C]-15-HETE, [14C]-12-HETE, [14C]-12-oxo-
ETE, [14C]-HxB3, or [
14C]-TrXB3 for 4 h at 37°C. Reactions were
stopped by adding a volume of a cold solution of 2% acetic acid in
methanol. Cells were then centrifuged and supernatants were stored at ±
80°C for further analysis. Pellets were suspended in 1.5 ml of 2% acetic
acid in methanol followed by 1.5 ml of water. Lipids were extracted
according to the method described by Bligh and Dyer (1959). Extracts
were dried under an N2 stream and the residues were redissolved in
35 ml of methanol:chloroform 1:2. Labeled phospholipids were analyzed
as previously described (Godessart et al, 1996).
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RP-HPLC analysis Chromatography was performed as previously
described (AntoÂn et al, 1998). Quantitative analysis of 12-LO-derived
compounds was done by injecting the samples directly into the column
without further manipulation. The column was then coupled on line
with a radioactivity detector (Beckman-171) equipped with a liquid
scintillation cell. Eluents were mixed with scintillation cocktail pumped
at 3 ml per min. Data from the detector were processed with a System
Gold Software Beckman in a PC computer.
When isolation of eluted material was required, fractions were
collected either on exit from the radioactivity detector equipped with a
solid scintillation cell, or from the column, depending on labeled or
unlabeled samples. In this way we collected fractions of TrXs at 4±
11 min, Hxs at 14±20 min, HODEs at 20±25 min, 12-oxo-ETE (and
also HODEs and 15-HETE) at 25±27 min, and HETEs 27±40 min.
These fractions were later concentrated by liquid±liquid extraction after
adjusting the MeOH:H2O ratio to 1:1. Dried extracts were then
derivatized for GC-MS analysis. Moreover, [1±14C]-AA from an internal
standard was collected in order to assess quantitative ester hydrolysis and
counted in a liquid scintillation counter. Both kinds of hydrolysis were
quantitative.
Derivatization All fractions except that of 12-oxo-ETE were
derivatized to their hydrogenated methyl ester trimethylsilyl ethers (ME-
H-TMS) as described previously (AntoÂn et al, 1998). 12-oxo-ETE was
®rst transformed into its methyl ester trimethylsilyl ether (ME-TMS), to
demonstrate it was not contaminated with 12-HETE, before
transformation to its ME-H-TMS derivative. All samples were dried and
redissolved in heptane/BSTFA.
GC-MS analysis Analysis by GC-MS was performed as previously
described (AntoÂn et al, 1995, 1998). In this case, the GC column was a
TRB-1 fused silica capillary column (15 m length, 0.25 mm internal
diameter, 0.25 mm ®lm thickness, Tracer AnalõÂtica, Barcelona, Spain).
The gas chromatograph and mass spectrometer were Hewlett-Packard
6890 series and 5973 model, respectively.
RESULTS
HxB3 and TrXs are present in the phospholipid fraction of
psoriatic lesions After isolation, the phospholipids were
hydrolyzed by two procedures: treatment with puri®ed PLA2 or
with KOH. Samples were then subjected to HPLC fractionation.
Hx and TrX fractions were then derivatized and subjected to GC-
MS analysis using the full scan mode. Monitoring suitable ions for
HxB3 (m/z 73, 269, 282, and 311), the ME-TMS derivatives of the
Hxs fraction from psoriatic scales subjected to GC-MS analysis
eluted as a single peak. The EI mass spectrum was consistent with
the structure of 10-hydroxy-11,12-epoxy-5,8,14-eicosatrienoic
acid (HxB3) and it was essentially identical to that obtained with
authentic (6)HxB3. (See our previous studies for details of mass
spectra (AntoÂn et al, 1995, 1998).) The fragments monitored in the
hydrogenated samples were at m/z 73, 257, 273, and 287. Samples
of phospholipids from psoriatic patients showed three peaks with
CN of 22.65, 22.80, and 22.96, essentially with identical mass
spectra consistent with the structure of hydrogenated HxB3. The
ME-H-TMS derivative of authentic (6)HxB3 yielded only two
peaks, at CN 22.80 and 22.96 (AntoÂn et al, 1995; 1998). Based on
these results, we concluded that not only the two 10-hydroxy
epimers of HxB3 were present in the phospholipids of psoriatic
lesions but, as occurred with the free acid fraction (AntoÂn et al,
1998), another isomer was also present. No HxB3 was detected in
the phospholipids of normal epidermis (n = 6) and heel callus from
normal and psoriatic subjects (n = 3). As expected, HxA3 was not
detected in the phospholipid fraction of either psoriatic scales or
normal epidermis as it was not stable under our work-up
conditions.
The ME-TMS derivatives of TrXs were analyzed monitoring m/
z 213 (corresponding to the methyl terminal fragment from
cleavage of the C11±C12 bond indicating the presence of a
hydroxyl group at C12) and 243 (corresponding to the carboxyl
terminal fragment from cleavage of the C8±C9 bond, which
indicates the presence of a hydroxyl group at C8), for both trioxilin
A3 (TrXA3) and 8,9,12-trihydroxyeicosatrienoic acid (8,9,12-
THETrE), and at m/z 269 (corresponding to the carboxyl terminal
fragment from cleavage of the C10±C11 bond indicating the
presence of a hydroxyl group at C10) for TrXB3. Three peaks
monitoring at m/z 213 showed essentially identical mass spectra
consistent with the structure of TrXA3 (see our previous papers for
details: AntoÂn et al, 1995, 1998). As occurred with the free acid
fraction of psoriatic scales (AntoÂn et al, 1998), the detection of three
GC peaks indicates the presence of at least three diastereoisomers of
TrXA3 in the phospholipid fraction of psoriatic scales. Monitoring
at m/z 269, two GC peaks had similar mass spectra consistent with
the TrXB3 structure. This indicates that the TrXB3 was present in
psoriatic samples as at least two diastereoisomeric forms.
Monitoring the 243 ion mass we observed two peaks consistent
with the structure of 8,9,12-THETrE. The presence of TrXs was
also con®rmed by GC-MS analysis of the hydrogenated fractions.
We were unable to detect TrXs in the phospholipids of normal
epidermis (n = 6) and in heel callus from normal and psoriatic
subjects (n = 3). Based on HPLC and GC-MS analysis we can
conclude that HxB3 and TrXs were present in the phospholipids of
psoriatic lesions. For quantitative analysis we selected the ME-H-
TMS derivatives of HXs, TrXs, HETEs, and HODEs as the most
suitable due to their structure-speci®c fragmentation and their high
relative intensity in the positive ion EI mode GC-MS (AntoÂn et al,
1998). As authentic TrXs were not commercially available, TrXs
were only semiquantitatively evaluated. Table I shows the quan-
titative data from the analysis of the phospholipid fraction of
psoriatic scales. As expected, we found that 12-HETE, 15-HETE,
13-HODE, and 9-HODE were present in signi®cant amounts in
the phospholipids of psoriatic lesions, 13-HODE being the most
abundant. HxB3 was also present. Apparently, the most abundant
triol in the phospholipids of psoriatic scales was TrXA3 followed by
TrXB3, whereas 8,9,12-THETrE was present in small amounts.
Results in Table I show that although the amount of all the
eicosanoids and octadecanoids analyzed was slightly lower in the
samples treated with PLA2, differences with respect to those in
which phospholipids were hydrolyzed with KOH failed to reach
signi®cance.
HxB3 and TrXB3 were mainly esteri®ed in phosphatidyl-
choline (PhC) and phosphatidyl-ethanolamine (PhE) To
observe the esteri®cation of the HxB3 and TrXB3 into the different
classes of phospholipids in comparison with 12-HETE, 12-oxo-
ETE, and 15-HETE, the radioactivity associated with each
phospholipid class was evaluated after incubation of epidermal
cell suspensions with 10 mM [14C]-labeled substrates for 4 h.
Results in Table II show that all eicosanoids tested were
incorporated into cell phospholipids 12-HETE > 15-HETE >
TrXB3 > 12-oxo-ETE > HxB3. Each eicosanoid exhibited a
characteristic pattern of esteri®cation, 12-HETE being the most
esteri®ed (PhC > PhE > phosphatidyl-serine (PhS) »
sphingomyelin (SPh) > phosphatidyl-inositol (PhI). PhC and PhE
were the phospholipid classes in which the eicosanoids were in
general mainly incorporated. In particular, esteri®cation of HxB3
and TrXB3 were only detectable in PhC > PhE. Results
concerning HxB3 in Table II are thus approximate, as a part of
the radioactivity associated with the phospholipids was probably
due to TrXB3. Whereas the amount of the 12-LO-derived
compounds incorporated into PhI was relatively low, however,
the relative amount of 15-HETE incorporated into PhI was
remarkable. It was also notable that the amount of 12-oxo-ETE
incorporated into PhS was the highest compared with the other
compounds assayed (PhS > PhC > PhE » PhI » SPh).
HxB3 was enzymatically transformed into TrXB3 by
epidermal cells Substrate concentration kinetics were
performed by incubating fragments of human epidermis with a
range of [14C]-AA for 30 min and then analyzing by HPLC.
Figure 1 shows a typical RP-HPLC chromatogram from samples of
human epidermis incubated with 100 mM [14C]-AA. As expected,
four peaks corresponding to 12-LO-derived eicosanoids were
observed, the identities of which were con®rmed by GC-MS
analysis: trioxilins (TrXB3, TrXA3, and 8,9,12-THETrE, which
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migrated unresolved), HxB3, 12-oxo-ETE, and 12-HETE. Results
in Fig 2 showed that 12-LO activity was almost linear in the range
of substrate concentrations assayed (5±100 mM) indicating that the
range assayed was far from that which would yield the apparent
maximum velocity. Results expressed as a ratio of each 12-LO-
derived eicosanoid to total 12-HPETE showed that 12-HETE
decreased as substrate concentration increased, whereas 12-oxo-
ETE and TrXs increased with substrate concentration. The relative
amount of HxB3 was similar in all AA concentrations tested,
suggesting that the rate of further transformations of HxB3
increased with the substrate concentration.
To observe further transformations of HxB3, suspensions of
human epidermal cells (20 3 106 cell per ml) were incubated with
10 mM of [14C]-HxB3, at 37°C for 4 h. Compounds in the
supernatant were analyzed. As Fig 3 shows, part of the HxB3 was
found transformed into TrXB3 (47.3% 6 11.7%, mean 6 SD,
n = 4). The identity of the TrXB3 HPLC peak (Fig 4) was
con®rmed by GC-MS analysis of parallel incubations with
nonlabeled material. We performed a full scan GC-MS of ME-
TMS derivatives of the collected peak corresponding to TrXB3.
Speci®c ion monitoring at m/z 269 was performed and two peaks
were observed (Fig 4). The two GC peaks had essentially identical
mass spectra consistent with the TrXB3 structure (AntoÂn et al, 1995;
1998), which was present in at least two stereoisomeric forms. For
additional support for the presence of two isomers of TrXB3 in the
incubates, the HPLC fraction was subjected to catalytical hydro-
genation and was analyzed by full scan GC-MS, monitoring the
speci®c ion m/z 273. Two GC peaks (Fig 4) with a fragmentation




ng per mg A/A12-HETE
b ng per mg A/A12-HETE
HxB3 1.7 6 0.1
c Ð 2.0 6 0.1 Ð
TrXB3 Ð 0.07 6 0.05 Ð 0.08 6 0.01
HxA3 Ð n.d.
d Ð n.d.
TrXA3 Ð 0.15 6 0.13 Ð 0.18 6 0.14
8,9,12-THETrE Ð 0.03 6 0.02 Ð 0.03 6 0.01
12-HETE 8.8 6 4.5 1 10.8 6 4.6 1
15-HETE 3.2 6 1.1 Ð 3.4 6 1.8 Ð
9-HODE 18.3 6 7.0 Ð 21.0 6 2.6 Ð
13-HODE 38.1 6 22.6 Ð 47.3 6 19.8 Ð
aThe internal standard was added, lipids were extracted, and phospholipids puri®ed and hydrolized by alkaline saponi®cation or by means of PLA2. Free acids were ex-
tracted, separated by HPLC, and derivatized to their ME-H-TMS derivatives prior to GC-MS analysis. Quanti®cation was performed taking into account the curves built
with authentic standards.
bAs standards were not available for TrXs, semiquantitative evaluation was accomplished by calculating the ratio of the area of the corresponding GC peak to that of 12-
HETE.
cMean 6 SD, n = 6.
dn.d., not detected.
Table II. 15-HETE, 12-HETE, 12-oxo-ETE, HxB3, and TrXB3 were esteri®ed in the different phospholipid classes
15-HETEa 12-HETE 12-oxo-ETE HxB3(+ TrXB3)
c TrXB3
PhC 1.55 6 1.22b 4.81 6 2.73 0.29 6 0.25 0.58 6 0.30 1.79 6 0.63
PhE 0.40 6 0.32 1.46 6 0.92 0.14 6 0.10 0.31 6 0.16 0.59 6 0.27
PhI 0.40 6 0.27 0.02 6 0.02 0.17 6 0.12 n.d.d n.d.
PhS 0.11 6 0.08 0.35 6 0.29 0.95 6 0.49 n.d. n.d.
SPh 0.04 6 0.03 0.20 6 0.07 0.08 6 0.05 n.d. n.d.
a0.5 ml of epidermal cell suspensions (20 3 106 cells per ml) were incubated with 10 mM of [14C]-labeled eicosanoids for 4 h and the radioactivity associated with the
indicated phospholipid classes was evaluated as previously described (Godessart et al, 1996).
bResults are expressed as pmoles of [14C]-labeled eicosanoid incorporated in 4 h by 106 cells, n = 4, mean 6 SD.
cThese results are approximate as part of the radioactivity associated with the phospholipids was due to TrXB3.
dNot detected.
Figure 1. Human epidermis produced trioxilins HxB3, 12-oxo-
ETE, and 12-HETE as the main 12-LO-derived eicosanoids.
Typical RP-HPLC chromatogram from samples of human epidermis
incubated with 100 mM [14C]-AA. Fragments of human epidermis were
incubated with 100 mM of [14C]-AA at 37°C for 30 min.
Chromatography was performed isocratically in a Ultrasphere-ODS
column (Beckman) with methanol:water:tri¯uoroacetic acid:triethylamine
75:25:0.1:0.05 pumped at 1 ml per min. The identity of the peaks was
con®rmed by GC-MS.
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consistent with a 10,11,12-trihydroxy-arachidic acid structure were
observed (AntoÂn et al, 1995, 1998).
The ``HxB3 epoxide hydrolase'' activity was located in the
cytosolic fraction To locate the ``HxB3 epoxide hydrolase''
activity, the supernatant and pellet, obtained after centrifugation of
homogenate epidermis at 100,000 3 g, were incubated with
10 mM [14C]-HxB3 and labeled eicosanoids were analyzed. The
enzymatic origin of TrXB3 was supported by the fact that boiled
tissue did not produce TrXB3 when incubated with [
14C]-HxB3
(Fig 5). The 100,000 3 g pellet did not transform HxB3 into
TrXB3; in contrast, the supernatant ef®ciently converted HxB3 into
TrXB3 (90.3 6 36.0 pmol per 30 min per 100 mg protein, mean
6 SD, n = 3).
DISCUSSION
Chromatographic behavior of HxB3 shows that it is a hydrophobic
compound but less so than monohydroxy acids. We expected that,
as occurred with other hydrophobic eicosanoids and octadecanoids,
HxB3 could remain associated to the lipid fractions and would be
retained in the in¯ammatory lesions. This concept is consistent
with the fact that nonesteri®ed HxB3 is notably elevated in psoriatic
lesions (AntoÂn et al, 1998). Nonpolar eicosanoids are not only
present in the in¯ammatory lesions as a free form but also tend to
esterify in cell phospholipids, which results in large amounts of
monohydroxy fatty acids esteri®ed into cell phospholipids in
in¯ammatory lesions (Baer et al, 1991; KuÈhn et al, 1992). Indeed,
among the eicosanoids and octadecanoids only the hydroxy and
epoxy derivatives have been reported to be incorporated into
cellular phospholipids (Stenson and Parker, 1979; Schade et al,
1987; Brezinski and Serhan, 1990; Wang et al, 1990; Brinkman et
al, 1991; Bernstrom et al, 1992). Here we report that HxB3 is also
present in psoriatic lesions esteri®ed in the phospholipids in an
HxB3:12-HETE ratio of 0.19 after both alkaline saponi®cation and
PLA2-catalyzed hydrolysis. This ratio is similar to that found on
analyzing free acids (0.15, from AntoÂn et al, 1998). The fact that
there were no signi®cant differences between alkaline- and PLA2-
catalyzed hydrolysis regarding HxB3 indicated that in psoriatic
lesions HxB3 is mainly esteri®ed in the sn-2 position of
glycerophospholipids. Esteri®ed HxB3 and TrXB3 were not
detected either in normal epidermis or heel callus from normal
and psoriatic subjects, indicating that they were not formed in
signi®cant amounts in places other than psoriatic lesions. Taking
into account that these compounds were also undetectable in the
Figure 2. Human epidermis produced trioxilins, HxB3, 12-oxo-
ETE, and 12-HETE in a concentration-dependent manner and
their relative amounts varied with the substrate concentration.
Epidermal fragments were incubated with 5, 10, 25, 50, 100 mM
concentration of [14C]-AA at 37°C for 30 min. Reactions were stopped
with one volume of cool methanol and samples were analyzed by RP-
HPLC. Chromatography was performed as described in Fig 1. Results
in the upper panel show the total 12-LO activity (evaluated as the sum of
all 12-LO-derived peaks). The bottom panel shows the relative amount of
each eicosanoid with respect to the total amount of 12-HPETE
produced. Mean 6 SD, n = 4.
Figure 3. HxB3 was slowly transformed into TrXB3 by epidermal
cells. Chromatogram obtained from a sample of the supernatant of
human epidermal cell suspension (20 3 106 cell per ml) incubated with
10 mM [14C]-HxB3 for 4 h at 37°C. One volume of cool methanol was
added to the supernatants and samples were analyzed by RP-HPLC.
Chromatography was performed as described in Fig 1. Part of the HxB3
was found transformed into TrXB3 (47.3% 6 11.7%, mean 6 SD,
n = 4). The identity of the TrXB3 peak was con®rmed by GC-MS
analysis of parallel incubations with nonlabeled material.
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free form in normal epidermis (AntoÂn et al, 1998), the presence of
HxB3 and TrXB3 seems to be a characteristic feature of the
psoriatic lesion.
Metabolism of AA in human epidermis through the 12-LO
pathway results in the formation of HxB3, 12-oxo-ETE, and
several triols in addition to 12-HETE (AntoÂn et al, 1995). In
particular, high amounts of HxB3 and 12-oxo-ETE are produced
by whole human epidermis. Unlike hemin-catalyzed formation of
HxB3, normal human epidermis only produced one of the two
possible 10-hydroxy epimers (AntoÂn et al, 1995; AntoÂn and Vila,
2000). Samples from authentic hydrogenated racemic HxB3 yielded
two GC peaks, which correspond to the two epimeric forms at C10
(AntoÂn et al, 1995; AntoÂn and Vila, 2000). As occurred regarding
free acids (AntoÂn et al, 1998), in addition to these two peaks
phospholipids of psoriatic samples yielded a major additional peak
with an MS spectrum also consistent with the structure of the
hydrogenated HxB3. As previously discussed (AntoÂn et al, 1998), it
is possible that other isomers of HxB3 corresponding to 10-
hydroxy-cis-epoxides may be formed by rearrangement of an AA-
peroxide radical intermediate as a result of an autocatalytic process
induced by free radicals.
Cellular phospholipids containing oxidized forms of AA or
linoleic acid could be originated in two ways: (i) direct oxidation of
the fatty acid substituents at the sn-1 or sn-2 positions of
glycerophospholipids and diacylglycerol and (ii) re-esteri®cation
of oxidized acids with lysoglycero-phospholipids. Enzymatic
oxidation of polyunsaturated lipids within glycerophosphatide
substrates has been demonstrated under certain conditions, par-
ticularly in cell-free systems using exogenously supplied 15-LO
(Brash et al, 1987; KuÈhn et al, 1990). Consistently, all compounds
tested were esteri®ed in vitro into phospholipids when epidermal
cells were incubated with labeled compounds. Our in vitro data and
data elsewhere (Brezinski and Serhan, 1990; Karara et al, 1991;
Legrand et al, 1991), argue in favor of remodeling as a signi®cative
origin of oxidized phospholipids in psoriatic lesions. We report
herein the generation of a new class of oxidized phospholipids by
esteri®cation of oxo, epoxy-hydroxy, and trihydroxy eicosanoids in
cell phospholipids, but to a lesser extent than hydroxy compounds.
Nevertheless, whereas HxB3 was found in the phospholipid
Figure 4. HxB3 was transformed into two isomers of TrXB3.
GC-MS selected ion chromatograms of ions characteristic of the ME-
TMS derivatives of the native (upper panel) and the hydrogenated ME-
TMS derivative of TrXB3 (bottom panel). Human epidermal cell
suspensions (20 3 106 cell per ml) were incubated with 10 mM [14C]-
HxB3 for 4 h at 37°C. One volume of cool methanol was added to the
supernatants and samples were subjected to RP-HPLC as described in
Fig 1. RP-HPLC peak corresponding to TrXB3 was collected and
derivatized. Full scan GC-MS of ME-TMS derivatives of native and
hydrogenated TrXB3 fraction were performed as described in Methods.
Figure 5. Formation of TrXB3 from HxB3 was enzymatic and
the HxB3 epoxide hydrolase-like activity was located in the
cytosolic fraction. Representative chromatograms of boiled epidermis
and cytosolic and microsomal fractions incubated with [14C]-HxB3 are
shown. Human epidermis was mechanically homogenized and
centrifuged at 100,000 3 g for 90 min at 4°C. Protein equivalent
amounts (250 mg) of boiled homogenate and 100,000 3 g supernatant
and pellet were incubated with 10 mM [14C]-HxB3 at 37°C for 30 min.
Reactions were stopped with one volume of cool methanol and samples
were analyzed by RP-HPLC. Chromatography was performed as
described in Fig 1. 100,000 3 g supernatant ef®ciently converted HxB3
into TrXB3 (90.3 6 36.0 pmol per 30 min per 100 mg protein, mean
6 SD, n = 3).
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fraction of psoriatic scales, 12-oxo-ETE was not detected in the
samples from psoriatic patients although it was esteri®ed when
incubated in vitro with epidermal cells. Indeed, neither was 12-oxo-
ETE found in the free form in psoriatic lesions (unpublished
results). This may be due to a further transformation of 12-oxo-
ETE in vivo; our results are not conclusive with respect to this
point.
Like 12-HETE, HxB3 and TrXB3 were mainly esteri®ed in PhC
and PhE. 12-oxo-ETE was esteri®ed into PhI, although, consist-
ently with data reported by others (Brezinski and Serhan, 1990;
Legrand et al, 1991; Girton et al, 1994), 15-HETE exhibited the
highest preference for PhI when compared with the other
compounds tested. The generation of oxidized phospholipids
may be of relevance, as these phospholipids interfere with PhC and
PhI signaling pathways by the generation of altered phosphatidic
acids and diacylglycerols (Brezinski and Serhan, 1990; Legrand et al,
1991, 1996; Cho and Ziboh, 1994a, b; Wallukat et al, 1994).
Accumulation of HxB3 in the sn-2 position of glyceropho-
spholipids could also serve as a storage pool for agonist-mediated
release of HxB3 from PhC and PhE.
Further conversion of HxB3 in human epidermis into TrXB3
could represent a pathway for hepoxilin inactivation. HxB3, which
was stable under our work-up conditions, was only enzymatically
transformed to TrXB3, as the conversion of HxB3 into TrXB3 was
abolished by tissue boiling. As normal epidermis exclusively
produces the 10(R)-hydroxy isomer of HxB3, the fact that we
detected two stereoisomers of TrXB3 suggests that they came from
the opening of the epoxide ring in C11±C12, rather than from the
two epimeric positions of the hydroxyl group at C10 in HxB3.
The ``HxB3 epoxide hydrolase'' activity was located almost
exclusively in the cytosol of the epidermal cells, as we only detected
TrXB3 in the 100,000 3 g supernatant fraction when incubated
with puri®ed [14C]-HxB3. The cytosolic location of ``HxB3
epoxide hydrolase'' in human epidermis is consistent with that
reported by Pace-Asciak and Lee (1989) who found ``hepoxilin
epoxide hydrolase'' activity in the 100,000 3 g supernatant of rat
liver homogenates, although the authors did not provide data about
the activity in the microsomal fraction. Nevertheless, the same
authors found hepoxilin epoxide hydrolase-like activity located in
the membrane fraction in platelets (Pace-Asciak et al, 1986). This
suggests that several hepoxilin epoxide hydrolase isoenzymes could
be expressed in different tissues.
TrXA3 was also present in the sn-2 position of glyceropho-
spholipids, strongly suggesting that HxA3 and/or TrXA3 were also
esteri®ed in the phospholipids. Nevertheless, we could not evaluate
the quantity of HxA3 present in the phospholipid fraction as HxA3
was not stable under our work-up conditions.
Support for the potential role of hepoxilins in the pathogenesis of
in¯ammatory skin diseases includes their potent action on plasma
permeability when injected subcutaneously (Laneuville et al, 1991;
Wang et al, 1996, 1999a, b) and the detection of a considerable
amount in psoriatic lesions in free form (AntoÂn et al, 1998) and also
esteri®ed. Hepoxilins could play an autocrine role as intracellular
messengers and a paracrine role modulating leukocyte activation
(reviewed in Pace-Asciak et al, 1999). The biologic role of these
compounds on dermatoses is at present under research in our
laboratory.
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